Rexahn Pharma (RNN) Commences RX-3117 Phase 1b/2a Stage 2 in r/r Metastatic Pancreatic Cancer
Tweet Send to a Friend
Rexahn Pharmaceuticals, Inc. (NYSE: RNN) announced it has initiated stage 2 of the Phase Ib/IIa clinical trial with the novel ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
